SF
EDIT icon

Synovus Financial’s Editas Medicine EDIT Stock Holding History

Synovus Financial’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-208
Closed -$6K – 888
2020
Q2 		$6K Buy
208
+100
+93% +$2.61K ﹤0.01% 1282
2020
Q1 		$2K Buy
108
+40
+59% +$1.01K ﹤0.01% 1934
2019
Q4 		$2K Buy
68
+60
+750% +$1.5K ﹤0.01% 1416
2019
Q3 		$0 Hold
8
– – ﹤0.01% 1446
2019
Q2 		$0 Hold
8
– – ﹤0.01% 1388
2019
Q1 		$0 Hold
8
– – ﹤0.01% 1425
2018
Q4 		$0 Hold
8
– – ﹤0.01% 1404
2018
Q3 		$0 Hold
8
– – ﹤0.01% 1393
2018
Q2 		$0 Buy
+8
New +$283 ﹤0.01% 1252

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Synovus Financial's EDIT Position: Q3 2020 in Review

Synovus Financial sold out of Editas Medicine (EDIT) in Q3 2020, closing a stake of 208 shares — an estimated $6K sold.

Synovus Financial first reported a position in EDIT in Q2 2018 and held it in 9 quarters. The position peaked at $6K in Q2 2020. 239 funds tracked by Wall St. Rank hold EDIT as of Q3 2020.

  • Synovus Financial reported no remaining Editas Medicine position as of Q3 2020 after selling out during the quarter.
  • Synovus Financial sold 208 Editas Medicine shares in Q3 2020, an estimated $6K.
  • Synovus Financial first reported a position in Editas Medicine in Q2 2018 and held it in 9 quarters.
  • Synovus Financial's Editas Medicine position peaked at $6K in Q2 2020.
  • 239 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2020.

Based on Synovus Financial's 13F filing for Q3 2020, filed 9 Nov 2020.